@Davisite
The Triangle report established a base case price for Bisantrene at $15K USD per month and possibly ranging from $12K-20K USD per month.
On the Keytruda website, they note the price per dose on a 3-week cycle to be $11,115 USD which works out to $14,820 per month (11,115 div 3 then x4).
As the 3-week dosing cycle represents the current protocols for breast cancer treatment, this places Bisantrene at a pricing scale of a base $11,250 USD per dose or within the range of $9K-15 USD per dose.
Given that other cancer types have different dosing protocols, would this price per dose for Bisantrene be consistent across those? if not, do you know roughly what price it would average out to?
@DavisiteThe Triangle report established a base case price for...
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.55 |
Change
-0.100(6.06%) |
Mkt cap ! $272.8M | |||
| Open | High | Low | Value | Volume |
| $1.71 | $1.71 | $1.55 | $224.6K | 139.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 2242 | $1.54 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.56 | 600 | 1 |
View Market Depth
| Last trade - 12.18pm 15/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.55 |
Change
-0.100 ( 7.86 %) |
||||
| Open | High | Low | Volume | ||
| $1.62 | $1.65 | $1.55 | 16855 | ||
| Last updated 12.12pm 15/05/2024 ? | |||||
| RAC (ASX) Chart |